Pfizer to See No Major M&A Activity in 2024: CEO Bourla
October 31, 2023
1,727
6
9
0.87%
Search the Record
IndexedEvery word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
Bloomberg Television Episodes Around October 31, 2023
See what was published immediately before and after this episode.
1:42Now PlayingPfizer to See No Major M&A Activity in 2024: CEO Bourla
YouTube Description
as posted by the channelPfizer Chairman and CEO Albert Bourla says the company is still in the market for acquisitions following its $43 billion acquisition of cancer biotech firm Seagen Inc., but 2024 will not see any major M&A activity from the company. He speaks with David Westin on "Wall Street Week Daily."
--------
Follow Bloomberg for business news & analysis, uptotheminute market data, features, profiles and more
Connect with us on...
Links & Promotions
Guests & Subjects Covered
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.